Table 3.
General characteristics of studies included in meta-analyses.
| Study characteristics | Year | Surgeries (LMGB versus ) | Number of patients | Gender (female/male) |
Age (years) | BMI (kg/m2) | Remission of T2DM# | %EWL# |
|---|---|---|---|---|---|---|---|---|
| Lee et al. [34] | 2007 | LAGB | 212 versus 37 | 177 versus 72 | 33 ± 9 | 26.58 ± 4.8 versus 31.13 ± 5.23 | NR | 78.54 ± 26.87 versus 43.65 ± 26.08∗ |
|
| ||||||||
| Liou et al. [36] | 2011 | LAGB | 371 versus 149 | 266/105 versus 83/66 | 30.7 ± 8.3 versus 31.9 ± 9.2 | 42 ± 6.2 versus 41.9 ± 6.3 | NR | NR |
|
| ||||||||
| Lee et al. [37] | 2013 | LAGB LSG |
33 versus 17 33 versus 12 |
39 versus 23 | 31.8 ± 9.2 | 41.7 ± 7.3 versus 41.7 ± 5 41.7 ± 7.3 versus 39.6 ± 0.7 |
84.8% versus s 58.8%∗
84.8% versus 58.3%∗ |
NR |
|
| ||||||||
| Musella et al. [38] | 2014 | LAGB LSG |
80 versus 120 80 versus 175 |
38/42 versus 75/45 38/42 versus 123/52 |
34.8 versus 39.5 34.8 versus 38.2 |
50.8 versus 42.3 50.8 versus 47.9 |
— 88% versus 80.7% |
79.5 versus 58.2∗ (36 months) 79.5 versus 68.3∗ (36 months) |
|
| ||||||||
| Yang et al. [40] | 2014 | LAGB LSG LRYGB |
89 versus 10 89 versus 32 89 versus 47 |
68/21 versus 5/5 68/21 versus 13/19 68/21 versus 35/12 |
32.1 ± 10.3 versus 34.8 ± 12.2 32.1 ± 10.3 versus 33.9 ± 9.4 32.1 ± 10.3 versus 33.2 ± 9.4 |
41.7 ± 5.6 versus 41.5 ± 6.8 41.7 ± 5.6 versus 42.4 ± 8.9 41.7 ± 5.6 versus 42.7 ± 7.0 |
NR | 72 ± 20 versus 16.1 ± 14.3∗
72 ± 20 versus 67.2 ± 18.4∗ 72 ± 20 versus 65.5 ± 23∗ |
|
| ||||||||
| Milone et al. [41] | 2013 | LSG | 16 versus 15 | 8/8 versus 8/7 | 39.3 ± 2.3 versus 37.26 ± 3.7 | 45.8 ± 5 versus 43.6 ± 2.99 | 87.5% versus 66.7% | NR |
|
| ||||||||
| Kular et al. [42] | 2014 | LSG | 72 versus 76 | NR | NR | 44 ± 3.1 versus 42 ± 5.2 | 92% versus 81%∗ | 63 ± 21.2 versus 69 ± 22.5∗ |
|
| ||||||||
| Lee et al. [43] | 2014 | LSG | 30 versus 30 | 22/8 versus 22/8 | 44.6 ± 8.6 versus 46.4 ± 8.1 | 30.2 ± 2.2 versus 31 ± 2.8 | NR | NR |
|
| ||||||||
| Lee et al. [45] | 2012 | LRYGB | 1163 versus 494 | 850/313 versus 362/132 | 32.3 ± 9.1 versus 33.5 ± 9.3 | 41.1 ± 6.1 versus 40.5 ± 5.8 | NR | 72.9 ± 19.3 versus 60.1 ± 20.4∗ |
|
| ||||||||
| Pu et al. [46] | 2012 | LRYGB | 47 versus 49 | 23/24 versus 21/28 | 44.44 ± 3.02 versus 44 ± 2.25 | 26.5 ± 2.11 versus 26.3 ± 2.19 | 91.4% versus 90.3% | NR |
|
| ||||||||
| Disse et al. [47] | 2014 | LRYGB | 20 versus 61 | 14/6 versus 43/18 | 49.5 versus 47 | 40.1 versus 42.3 | 62.5% versus 26% | 89 versus 71∗ |
NR: not reported; ∗ P < 0.05; #one-year postoperative results.